niacinamide has been researched along with alprostadil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ban, M; Enomoto, I; Hashimoto, H; Ito, T; Ogawa, K; Sakai, K | 1 |
| Fukasawa, M; Fukui, K; Hirooka, S; Kohi, M; Orita, H; Uchino, H; Washio, M | 2 |
| Heldin, CH; Ostman, A; Pietras, K; Rubin, K | 1 |
| Hussar, DA | 1 |
| Bito, T; Hirai, M; Hirano, T; Ishida, T; Nakagawa, T; Nishigori, C; Shichiri, H; Tokura, M; Uda, A; Yamamoto, K; Yano, I | 1 |
1 review(s) available for niacinamide and alprostadil
| Article | Year |
|---|---|
High interstitial fluid pressure - an obstacle in cancer therapy.
Topics: Alprostadil; Animals; Antineoplastic Agents; Biological Transport; Bradykinin; Extracellular Fluid; Humans; Hyaluronoglucosaminidase; Hydrostatic Pressure; Mice; Neoplasms; Niacinamide; Platelet-Derived Growth Factor; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2004 |
6 other study(ies) available for niacinamide and alprostadil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
SG-75 induction of increased coronary outflow and PGE1 from ischemic areas in dogs with experimental myocardial infarction.
Topics: Alprostadil; Animals; Coronary Circulation; Dinoprostone; Dogs; Indomethacin; Lactates; Myocardial Infarction; Myocardium; Niacinamide; Nicorandil; Prostaglandins E; Vasodilator Agents | 1982 |
In vitro evaluation of nicorandil, diltiazem, and prostaglandin E1 on hypothermic injury to immature myocytes.
Topics: Alprostadil; Animals; Animals, Newborn; Cell Death; Cells, Cultured; Cold Temperature; Creatine Kinase; Diltiazem; Female; Heart Rate; Heart Ventricles; L-Lactate Dehydrogenase; Myocardium; Niacinamide; Nicorandil; Rats; Rats, Wistar; Ventricular Function | 1995 |
Cytoprotective effects of nicorandil on hypothermic injury to immature cardiac myocytes--comparison with nitroglycerin, diltiazem and prostaglandin E1.
Topics: Alprostadil; Animals; Cells, Cultured; Cold Temperature; Creatine Kinase; Cryopreservation; Cryoprotective Agents; Diltiazem; Heart; L-Lactate Dehydrogenase; Myocardium; Niacinamide; Nicorandil; Nitroglycerin; Rats; Vasodilator Agents | 1994 |
New drugs 07, part I.
Topics: Abatacept; Acetanilides; Alprostadil; Anidulafungin; Antidiuretic Hormone Receptor Antagonists; Antifungal Agents; Antineoplastic Agents; Arabinonucleosides; Benzazepines; Benzenesulfonates; Drug Approval; Drug Interactions; Drug Monitoring; Drug Therapy; Echinocandins; Fatty Acids; Humans; Hypoglycemic Agents; Immunoconjugates; Immunosuppressive Agents; Indoles; Insulin; Insulin Detemir; Insulin, Long-Acting; Intercellular Signaling Peptides and Proteins; Lenalidomide; Lubiprostone; Niacinamide; Patient Education as Topic; Peptides, Cyclic; Phenylurea Compounds; Piperazines; Pyridines; Pyrroles; Ranolazine; Sorafenib; Sunitinib; Thalidomide; United States | 2007 |
Prostaglandin E
Topics: Alprostadil; Antineoplastic Agents; Cell Line; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Hand-Foot Syndrome; Humans; Keratinocytes; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Skin; Sorafenib; STAT3 Transcription Factor | 2017 |